beebab; said:
question. what's the best way to dose Chromium Picolinate for optimal insulin management?
Letters: Comments and Responses
Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile: A Randomized, Placebo-Controlled, Double-Blind Trial of Supplementation in Subjects With Impaired Glucose Tolerance
Response to Gunton et al.
James Komorowski, MS and Vijaya Juturu, PHD
Technical Services & Scientific Affairs Department, Nutrition 21, Inc., Purchase, New York
Address correspondence to Vijaya Juturu, PhD, Nutrition 21, Inc., 4 Manhattanville Rd., Purchase, NY 10577. E-mail: vjuturu{at}nutrition21.com
We read the recent article by Gunton et al. (1) with great interest and feel that it warrants comment. In this study, the authors stated that they "found no beneficial effect of chromium supplementation in the treatment of people with IGT [impaired glucose tolerance]." The results are in conflict with other clinical studies that showed chromium picolinate can enhance or normalize impaired glucose metabolism, as described in a recent review (2). The lack of effect described by the authors may be explained by the apparent low dose of elemental chromium used in the study.
The authors stated that the chromium picolinate "dose (at 800 µg/day) was at the higher end of the ranges used in previous studies" (1). However, chromium picolinate administered at 800 µg per day yields a daily dose of 100 µg per day of elemental chromium (i.e., chromium picolinate contains 12.4% elemental chromium). An elemental chromium dose of 100 µg a day is half of the suggested minimum amount (200 µg) of elemental chromium previously shown to exhibit efficacy in glucose and lipid metabolism (2). A daily dose of 200–1,000 µg of elemental chromium, as chromium picolinate, is the efficacious dosage range used in previous studies.
Bullivants Natural Health Products, the supplier of the study products used by the authors, stated that 400 µg of the chromium picolinate product they produce yields 50 µg of elemental chromium. The study was conducted in Australia, and the 50-µg elemental chromium dose is also the maximum daily dose allowed by the Australian Therapeutic Goods Administration (3).
It was also interesting to note that although the serum chromium levels significantly rose in the active group, the serum chromium levels were not significantly higher in the active group than in the placebo group after 3 months of supplementation (active group 5.2 ± 8.9 nmol/l, placebo group 4.4 ± 4.0 nmol/l). For these reasons, we believe study subjects in the active group may have been administered daily doses of 50 µg elemental chromium, twice daily.
We recommend future studies be conducted in people with impaired glucose tolerance (following criteria defined by the American Diabetes Association) using daily doses of chromium picolinate providing ≥200–1,000 µg of elemental chromium for at least 90 days. We also recommend evaluating efficacy using the 75-g oral glucose tolerance test with calculation of the area under the curve using the trapezoidal method.
Footnotes
The authors are employees of Nutrition 21, Inc., which manufactures products containing chromium.
References
1. Gunton JE, Cheung NW, Hitchman R, Hams G, O’Sullivan C, Foster-Powell K, McElduff A: Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diabetes Care 28:712–713, 2005[Free Full Text]
2. Cefalu WT, Hu FB: Role of chromium in human health and in diabetes. Diabetes Care 27:2741–2751, 2004[Free Full Text]
3. Complementary Medicines Evaluation Committee (CMEC), meeting 41, 1 August 2003, public recommendation summary [summary online]. Available at
Invalid Link Removed. Accessed 1 August 2003